• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed

    2/8/21 10:15:35 AM ET
    $APH
    Electrical Products
    Technology
    Get the next $APH alert in real time by email
    SC 13G/A 1 filing.txt SCHEDULE 13G Amendment No. 21 AMPHENOL CORPORATION NEW CLASS A COMMON STOCK Cusip #032095101 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #032095101 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 3,893,678 Item 6: 0 Item 7: 21,671,355 Item 8: 0 Item 9: 21,671,355 Item 11: 7.244% Item 12: HC Cusip #032095101 Item 1: Reporting Person - Abigail P. Johnson Item 2: (a) [ ] (b) [ ] Item 4: United States of America Item 5: 0 Item 6: 0 Item 7: 21,671,355 Item 8: 0 Item 9: 21,671,355 Item 11: 7.244% Item 12: IN Item 1(a). Name of Issuer: AMPHENOL CORPORATION NEW Item 1(b). Address of Issuer's Principal Executive Offices: 358 Hall Avenue Wallingford, CT 06492 Item 2(a). Name of Person Filing: FMR LLC Item 2(b). Address or Principal Business Office or, if None, Residence: 245 Summer Street, Boston, Massachusetts 02210 Item 2(c). Citizenship: Not applicable Item 2(d). Title of Class of Securities: CLASS A COMMON STOCK Item 2(e). CUSIP Number: 032095101 Item 3. This statement is filed pursuant to Rule 13d-1(b) or 13d-2(b) or (c) and the person filing, FMR LLC, is a parent holding company in accordance with Section 240.13d-1(b)(1)(ii)(G). (Note: See Exhibit A). Item 4. Ownership (a) Amount Beneficially Owned: 21,671,355 (b) Percent of Class: 7.244% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: 3,893,678 (ii) shared power to vote or to direct the vote: 0 (iii) sole power to dispose or to direct the disposition of: 21,671,355 (iv) shared power to dispose or to direct the disposition of: 0 Item 5. Ownership of Five Percent or Less of a Class. Not applicable. Item 6. Ownership of More than Five Percent on Behalf of Another Person. One or more other persons are known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the CLASS A COMMON STOCK of AMPHENOL CORPORATION NEW. No one other person's interest in the CLASS A COMMON STOCK of AMPHENOL CORPORATION NEW is more than five percent of the total outstanding CLASS A COMMON STOCK. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. See attached Exhibit A. Item 8. Identification and Classification of Members of the Group. Not applicable. Item 9. Notice of Dissolution of Group. Not applicable. Item 10. Certifications. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Signature After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. February 5, 2021 Date /s/ Kevin M. Meagher Signature Kevin M. Meagher Duly authorized under Power of Attorney effective as of September 28, 2018, by and on behalf of FMR LLC and its direct and indirect subsidiaries* * This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on October 9, 2018, accession number: 0000315066-18-002414. Exhibit A Pursuant to the instructions in Item 7 of Schedule 13G, the following table lists the identity and Item 3 classification, if applicable, of each relevant entity that beneficially owns shares of the security class being reported on this Schedule 13G. Entity ITEM 3 Classification Crosby Advisors LLC N/A FIAM LLC IA Fidelity Institutional Asset Management Trust Company BK Fidelity Management & Research Company LLC * IA Strategic Advisers LLC IA * Entity beneficially owns 5% or greater of the outstanding shares of the security class being reported on this Schedule 13G. Abigail P. Johnson is a Director, the Chairman and the Chief Executive Officer of FMR LLC. Members of the Johnson family, including Abigail P. Johnson, are the predominant owners, directly or through trusts, of Series B voting common shares of FMR LLC, representing 49% of the voting power of FMR LLC. The Johnson family group and all other Series B shareholders have entered into a shareholders' voting agreement under which all Series B voting common shares will be voted in accordance with the majority vote of Series B voting common shares. Accordingly, through their ownership of voting common shares and the execution of the shareholders' voting agreement, members of the Johnson family may be deemed, under the Investment Company Act of 1940, to form a controlling group with respect to FMR LLC. Neither FMR LLC nor Abigail P. Johnson has the sole power to vote or direct the voting of the shares owned directly by the various investment companies registered under the Investment Company Act ("Fidelity Funds") advised by Fidelity Management & Research Company LLC ("FMR Co. LLC"), a wholly owned subsidiary of FMR LLC, which power resides with the Fidelity Funds' Boards of Trustees. FMR Co. LLC carries out the voting of the shares under written guidelines established by the Fidelity Funds' Boards of Trustees. This filing reflects the securities beneficially owned, or that may be deemed to be beneficially owned, by FMR LLC, certain of its subsidiaries and affiliates, and other companies (collectively, the "FMR Reporters"). This filing does not reflect securities, if any, beneficially owned by certain other companies whose beneficial ownership of securities is disaggregated from that of the FMR Reporters in accordance with Securities and Exchange Commission Release No. 34-39538 (January 12, 1998). RULE 13d-1(k)(1) AGREEMENT The undersigned persons, on February 5, 2021, agree and consent to the joint filing on their behalf of this Schedule 13G in connection with their beneficial ownership of the CLASS A COMMON STOCK of AMPHENOL CORPORATION NEW at December 31, 2020. FMR LLC By /s/ Kevin M. Meagher Kevin M. Meagher Duly authorized under Power of Attorney effective as of September 28, 2018, by and on behalf of FMR LLC and its direct and indirect subsidiaries* Abigail P. Johnson By /s/ Kevin M. Meagher Kevin M. Meagher Duly authorized under Power of Attorney effective as of September 30, 2018, by and on behalf of Abigail P. Johnson* * This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on October 9, 2018, accession number: 0000315066-18-002414.
    Get the next $APH alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $APH

    DatePrice TargetRatingAnalyst
    4/24/2025$85.00Equal Weight → Overweight
    Fox Advisors
    9/4/2024$80.00 → $71.00Buy → Neutral
    BofA Securities
    7/23/2024$65.00Hold
    Vertical Research
    5/20/2024$150.00Buy
    Seaport Research Partners
    4/9/2024$125.00Hold
    Jefferies
    1/5/2024$117.00Buy
    Citigroup
    10/5/2023$93.00Outperform
    Exane BNP Paribas
    5/19/2023$91.00 → $77.00Outperform → Neutral
    Credit Suisse
    More analyst ratings

    $APH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Livingston Robert bought $1,004,066 worth of shares (11,839 units at $84.81), increasing direct ownership by 25% to 59,120 units (SEC Form 4)

    4 - AMPHENOL CORP /DE/ (0000820313) (Issuer)

    11/9/23 9:14:36 AM ET
    $APH
    Electrical Products
    Technology

    $APH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President, CS Division Doherty William J exercised 226,000 shares at a strike of $22.55 and sold $24,767,589 worth of shares (226,000 units at $109.59) (SEC Form 4)

    4 - AMPHENOL CORP /DE/ (0000820313) (Issuer)

    8/12/25 4:03:20 PM ET
    $APH
    Electrical Products
    Technology

    VP & Corporate Controller Ivas Michael R. exercised 50,000 shares at a strike of $18.23 and sold $5,500,820 worth of shares (50,000 units at $110.02) (SEC Form 4)

    4 - AMPHENOL CORP /DE/ (0000820313) (Issuer)

    8/12/25 4:01:15 PM ET
    $APH
    Electrical Products
    Technology

    President, HES Division Walter Luc exercised 286,000 shares at a strike of $22.55 and sold $26,148,522 worth of shares (286,000 units at $91.43) (SEC Form 4)

    4 - AMPHENOL CORP /DE/ (0000820313) (Issuer)

    6/3/25 4:53:05 PM ET
    $APH
    Electrical Products
    Technology

    $APH
    SEC Filings

    View All

    SEC Form 144 filed by Amphenol Corporation

    144 - AMPHENOL CORP /DE/ (0000820313) (Subject)

    8/8/25 4:39:05 PM ET
    $APH
    Electrical Products
    Technology

    Amphenol Corporation filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - AMPHENOL CORP /DE/ (0000820313) (Filer)

    8/4/25 7:08:14 AM ET
    $APH
    Electrical Products
    Technology

    SEC Form 10-Q filed by Amphenol Corporation

    10-Q - AMPHENOL CORP /DE/ (0000820313) (Filer)

    7/25/25 4:06:08 PM ET
    $APH
    Electrical Products
    Technology

    $APH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Audax Private Equity Announces Sale of Trexon

    The sale, marking a significant realization for the Fund IV continuation fund, represents the 11th announced or completed exit for Audax Private Equity since August 2024. Audax Private Equity ("Audax"), a capital partner for middle and lower middle market companies, announced today it has agreed to the sale of Trexon ("The Company"), a designer and manufacturer of custom interconnect solutions for mission critical applications. The sale to Amphenol Corporation (NYSE:APH) is subject to customary closing conditions and expected to close in the fourth quarter of 2025. Headquartered in Boston, MA, with 1,100 employees globally, Trexon delivers custom-engineered interconnect solutions, inclu

    8/18/25 8:39:00 AM ET
    $APH
    Electrical Products
    Technology

    Amphenol Corporation to Acquire Trexon

    Amphenol Corporation (NYSE:APH) today announced a definitive agreement to acquire Trexon for approximately $1 billion in cash, subject to customary post-closing adjustments. Trexon is a leading provider of high-reliability interconnect and cable assemblies primarily for the defense market. Headquartered in Boston, Massachusetts and with facilities in the U.S. and the U.K., Trexon is expected to have 2025 sales and EBITDA margins of approximately $290 million and 26%, respectively. "We are extremely pleased to announce this agreement to add Trexon to the Amphenol family," said Amphenol President and Chief Executive Officer, R. Adam Norwitt. "Trexon's unique portfolio of high-reliability ca

    8/18/25 8:00:00 AM ET
    $APH
    Electrical Products
    Technology

    CommScope Reports Second Quarter 2025 Results

    Second Quarter Highlights Net sales of $1.39 billion GAAP income from continuing operations of $29.4 million Non-GAAP adjusted EBITDA of $337.8 million (1) Cash flow generated by operations of $77.1 million and free cash flow of $64.5 million (1) (2) (1) See "Non-GAAP Financial Measures" and "Reconciliation of GAAP Measures to Non-GAAP Adjusted Measures" below. (2) The cash flows related to discontinued operations have not been segregated. Accordingly, this cash flow information includes the results of continuing and discontinued operations. CommScope Holding Company, Inc. (NASDAQ:COMM), a global leader in network connectivity solutions, today reported results for the quart

    8/4/25 7:15:00 AM ET
    $APH
    $COMM
    Electrical Products
    Technology
    Radio And Television Broadcasting And Communications Equipment

    $APH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Amphenol upgraded by Fox Advisors with a new price target

    Fox Advisors upgraded Amphenol from Equal Weight to Overweight and set a new price target of $85.00

    4/24/25 8:24:52 AM ET
    $APH
    Electrical Products
    Technology

    Amphenol downgraded by BofA Securities with a new price target

    BofA Securities downgraded Amphenol from Buy to Neutral and set a new price target of $71.00 from $80.00 previously

    9/4/24 7:19:35 AM ET
    $APH
    Electrical Products
    Technology

    Vertical Research initiated coverage on Amphenol with a new price target

    Vertical Research initiated coverage of Amphenol with a rating of Hold and set a new price target of $65.00

    7/23/24 6:20:08 AM ET
    $APH
    Electrical Products
    Technology

    $APH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Amphenol Corporation (Amendment)

    SC 13G/A - AMPHENOL CORP /DE/ (0000820313) (Subject)

    2/13/24 4:58:53 PM ET
    $APH
    Electrical Products
    Technology

    SEC Form SC 13G/A filed by Amphenol Corporation (Amendment)

    SC 13G/A - AMPHENOL CORP /DE/ (0000820313) (Subject)

    2/9/24 8:35:56 AM ET
    $APH
    Electrical Products
    Technology

    SEC Form SC 13G/A filed by Amphenol Corporation (Amendment)

    SC 13G/A - AMPHENOL CORP /DE/ (0000820313) (Subject)

    2/9/23 11:07:31 AM ET
    $APH
    Electrical Products
    Technology

    $APH
    Leadership Updates

    Live Leadership Updates

    View All

    HealthEdge Announces Successful Sale of LifeSync to Amphenol

    TAMPA, Fla. and CORAL SPRINGS, Fla., Feb. 18, 2025 /PRNewswire/ -- HealthEdge Investment Partners, LLC ("HealthEdge"), a lower middle market private equity fund focused on healthcare, announced today that it has completed the sale of LifeSync ("LifeSync" or the "Company"), a developer, manufacturer, and marketer of disposable and reusable patient monitoring devices and connections sold to hospitals and other high acuity settings. LifeSync was acquired by Amphenol (NYSE:APH), one of the world's largest providers of connectors, interconnect systems, antennas, sensors and specialty cable. "When we first invested in LifeSync, our objective was to grow revenues and scale an entrepreneurial busin

    2/18/25 8:30:00 AM ET
    $APH
    Electrical Products
    Technology

    $APH
    Financials

    Live finance-specific insights

    View All

    CommScope Reports Second Quarter 2025 Results

    Second Quarter Highlights Net sales of $1.39 billion GAAP income from continuing operations of $29.4 million Non-GAAP adjusted EBITDA of $337.8 million (1) Cash flow generated by operations of $77.1 million and free cash flow of $64.5 million (1) (2) (1) See "Non-GAAP Financial Measures" and "Reconciliation of GAAP Measures to Non-GAAP Adjusted Measures" below. (2) The cash flows related to discontinued operations have not been segregated. Accordingly, this cash flow information includes the results of continuing and discontinued operations. CommScope Holding Company, Inc. (NASDAQ:COMM), a global leader in network connectivity solutions, today reported results for the quart

    8/4/25 7:15:00 AM ET
    $APH
    $COMM
    Electrical Products
    Technology
    Radio And Television Broadcasting And Communications Equipment

    Amphenol Corporation to Acquire Connectivity and Cable Solutions Business From CommScope

    Transaction highlights: To acquire CommScope's Connectivity and Cable Solutions business for $10.5 billion in cash Adds significant fiber optic interconnect capabilities for the IT datacom and communications networks markets as well as a diverse range of industrial interconnect products for the building infrastructure connectivity market Highly complementary to Amphenol's existing product offerings Anticipates CCS will generate sales and EBITDA margins of approximately $3.6 billion and 26% in 2025, respectively Expected to be accretive to Amphenol's Diluted EPS in first full year after closing Amphenol Corporation (NYSE:APH) today announced a definitive agreement to acquir

    8/4/25 7:00:00 AM ET
    $APH
    $COMM
    Electrical Products
    Technology
    Radio And Television Broadcasting And Communications Equipment

    CommScope to Sell its Connectivity and Cable Solutions Segment to Amphenol Corporation for $10.5 billion

    CommScope (NASDAQ:COMM), a global leader in network connectivity, announced today it has entered into a definitive agreement to sell its Connectivity and Cable Solutions (CCS) segment to Amphenol Corporation (NYSE:APH). CommScope (the "Company") is selling its CCS business to Amphenol for approximately USD $10.5 billion in cash, to be paid by Amphenol upon closing. The sale is expected to close within the first half of 2026, subject to customary closing conditions, including receipt of applicable regulatory approvals and the affirmative vote of the shareholders. The vote is required under Delaware law due to the nature and size of the transaction. The Company expects net proceeds after

    8/4/25 7:00:00 AM ET
    $APH
    $CG
    $COMM
    Electrical Products
    Technology
    Investment Managers
    Finance